• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    市

    市立奈良病院

    Nara City Hospital
    EST. 1909
    432论文总数
    8,133引用总数

    论文量&引用量时间轴

    机构学者

    论文(432)

    年份
    起
    –
    止
    排序
    1The Use of Diluted Epinephrine During Gastric Endoscopic Submucosal Dissection: an International Randomized Controlled Trial.
    Hon Chi Yip,Noriya Uedo,Hiroyoshi Iwagami,Kotaro Waki,Kensei Ohtsu,Masaki Miyaoka,Kenshi Yao,Takuji Akamatsu,Takafumi Konishi,Shogo Nakano,Hiroyoshi Nakanishi,Hisashi Doyama,

    BACKGROUND AND AIMS:Endoscopic submucosal dissection (ESD) is the standard treatment for early gastric cancer. Intraprocedural bleeding during gastric ESD may result in prolonged procedure time. Therefore, we investigated the efficacy of adding diluted epinephrine to a submucosal injection solution to reduce the procedure time in gastric ESD. METHODS:This international, multicenter, randomized controlled trial was conducted across 12 institutions. Patients with gastric mucosal neoplasia who underwent ESD were eligible. The patients were randomly allocated to either the epinephrine group (1:100,000 diluted epinephrine-added injection solution) or the control group. Randomization was stratified according to lesion location, size, and institution. Patients, endoscopists, and assessors were blinded to the treatment allocation. The primary outcome was the procedure time. Secondary outcomes included the number of intraprocedural hemorrhages requiring the use of hemostatic forceps and postprocedural adverse events. RESULTS:A total of 800 patients were enrolled, 774 of whom were included in the final modified intention-to-treat analysis. A total of 386 and 388 patients were randomized into the epinephrine and control groups, respectively. The mean (SD) procedure time was significantly shorter in the epinephrine group than in the control group: 60 (46) versus 68 (45) minutes, respectively (P = .018). The number of intraprocedural hemorrhages requiring hemostatic forceps was significantly lower in the epinephrine group (mean count: 1.8 vs 3.0; P < .001). There were no significant differences in postprocedural adverse events between the groups. CONCLUSIONS:The addition of diluted epinephrine to the injection solution significantly reduces the procedure time for gastric ESD. (ClinicalTrials.gov: NCT04032119.).

    2026Gastrointestinal endoscopy(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Epidemiology of Second Attack of Cardiovascular Events in Patients with Type 2 Diabetes
    Kenji Kuroki,Fumihiro Sakakibara,Mio Sakuma,Hisao Ogawa,Hirofumi Soejima,Sadanori Okada,Izuru Masuda,Masako Waki,Hideaki Jinnouchi,Yoshihiko Saito,Takeshi Morimoto

    The incremental risks of cardiovascular disease (CVD) after the first CVD event remain unclear because of the difficulty of assessing how risks changed from the pre-event to the post-event period. A long-term follow-up study was conducted in patients with type 2 diabetes. The endpoints were CVD, defined as ischemic stroke (IS) or coronary artery disease (CAD), and all-cause mortality. Two cohorts were defined: the pre-event and post-event cohorts. The incidence was analyzed using the Kaplan–Meier method, and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards models. The post-event cohort was further stratified by the type of the first event (IS or CAD). Among 2535 participants, 317 had a first CVD event, and 293 were included in the post-event cohort. Compared with the pre-event cohort, the post-event cohort had significantly higher risks of recurrent CVD (adjusted HR 2.24, 95% CI 1.63–3.06) and all-cause mortality (adjusted HR 2.07, 95% CI 1.59–2.69). Within the post-event cohort, recurrent CVD risk showed no difference between the IS and CAD groups, but all-cause mortality was significantly higher in the IS group. Patients with type 2 diabetes who experienced a first CVD event had a twofold increased risk of recurrent CVD events and all-cause mortality.

    2026Journal of Cardiovascular Development and Disease(2026)
    引用
    AI阅读
    加入学术空间
    3Community Standard Practices in the Endoscopic Treatment of Esophageal Squamous Cell Carcinoma: a Nationwide Survey in Japan
    Takuto Hikichi,Yugo Iwaya,Ryu Ishihara,Katsunori Iijima,Hironari Shiwaku,Tsutomu Nishida,Youichi Kumagai,Tomohiro Kadota,Hideki Kobara,Toshiyuki Yoshio,Osamu Dohi,Manabu Takeuchi,

    In Japan, endoscopic submucosal dissection (ESD) is the standard treatment for superficial esophageal squamous cell carcinoma (ESCC). Although clinical guidelines outline indications, additional treatment, and stricture prevention, real-world practice patterns remain insufficiently characterized. The present nationwide survey aimed to clarify the current endoscopic management of ESCC in Japan. A web-based, 20-item multiple-choice questionnaire was distributed to endoscopists performing upper gastrointestinal endoscopy at least weekly. Invitations were disseminated through the mailing lists of the Japan Esophageal Society and the individual mailing lists of core study members. The survey assessed diagnostic strategies, endoscopic treatment selection, indications for additional therapy after ESD, and approaches to stricture prevention. Altogether, 303 endoscopists who had performed endoscopic treatment for ESCC within the preceding year were enrolled. Most respondents reported using ESD exclusively. For clinical muscularis mucosa (MM) or shallow submucosa (SM1) lesions, treatment selection depended on circumferential extent, with ESD performed on 95.0

    2026Esophagus(2026)
    引用
    AI阅读
    加入学术空间
    4Evaluating Risk Factors Associating with Late Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer Using Machine Learning.
    Kenta Onishi,Tomonori Nakahama,Yasushi Nakai,Akira Tachibana,Yuki Oda,Mitsuru Tomizawa,Yosuke Morizawa,Shunta Hori,Daisuke Gotoh,Makito Miyake,Isao Asakawa,Kaori Yamaki,

    BACKGROUND:The Phoenix definition is widely used to define biochemical recurrence (BCR) after radiation therapy for prostate cancer; however, a definitive definition of cure remains unclear. This study aimed to identify factors associated with late BCR after low-dose-rate brachytherapy (LDR-BT), defined as BCR occurring ≥ 5 years after treatment among patients who remained recurrence-free during the first 5 years, using machine-learning methods. METHODS:We retrospectively analyzed 1419 patients who underwent LDR-BT between 2004 and 2019. Of these, 52 (3.7%) experienced BCR within 5 years, and 244 patients did not have ≥ 5 years of follow-up because of death or loss to follow-up. The remaining 1123 patients were recurrence-free at 5 years and formed the analysis cohort for late BCR (≥ 5 years). Random survival forest (RSF) and survival decision-tree analyses were applied to identify predictive factors, and recurrence-free survival was estimated using the Kaplan-Meier method. RESULTS:The 10-year BCR-free survival rate was 94.8%. RSF identified the 5-year prostate-specific antigen (PSA) value, PSA doubling time (PSA-DT) at 5 years, primary Gleason pattern, and NCCN risk classification as the most important predictors. Optimal cutoff values were 0.93 ng/mL for PSA at 5 years and 5.3 years for PSA-DT. Patients with lower PSA or longer PSA-DT had significantly higher 10-year recurrence-free rates than those at higher risk (97.3% vs. 11.1% and 99.0% vs. 68.1%, respectively; p < 0.001). CONCLUSIONS:PSA level and PSA-DT at 5 years were strong predictors of late BCR after LDR-BT. These findings suggest that follow-up intervals may be safely extended for low-risk patients, thereby reducing the burden of hospital visits and healthcare costs.

    2026The Prostate(2026)
    引用
    AI阅读
    加入学术空间
    5Distinct Clinical Course and Poor Outcomes of Small Bowel Bleeding in Acute Hematochezia: a Nationwide Multicenter Study
    Yuga Komaki,Naoyuki Tominaga,Atsuo Yamada,Eiji Sadashima,Katsumasa Kobayashi,Atsushi Yamauchi,Jun Omori,Takashi Ikeya,Taiki Aoyama,Yoshinori Sato,Takaaki Kishino,Naoki Ishii,

    Although small bowel bleeding is a known cause of acute lower gastrointestinal bleeding (ALGIB), its outcomes compared to colorectal bleeding remain underexplored. This study aimed to identify baseline characteristics and short- and long-term outcomes associated with small bowel bleeding in comparison to colorectal bleeding. This nationwide retrospective cohort study, based on CODE BLUE-J study, involved 10,342 patients hospitalized for ALGIB. Among 195 patients (2.8%) with acute small bowel bleeding, significant associations were observed with laboratory parameters (e.g., low hemoglobin, platelets, and albumin), clinical signs (e.g., tarry stool), and medical history, compared to 6832 patients with colorectal bleeding. Multivariate regression analysis showed no significant difference in 30-day rebleeding or mortality between small bowel and colorectal bleeding. However, small bowel bleeding was associated with higher transfusion volume, lower endoscopic treatment rate, higher rates of interventional radiology and surgery, and longer hospital stay (all p < 0.005). While long-term cumulative rebleeding rates were similar, cumulative mortality was significantly higher in the small bowel bleeding group (p < 0.001). This large-scale endoscopic study revealed differences in several clinical factors at presentation and in short- and long-term outcomes between small bowel and colorectal bleeding. These findings underscore importance of identifying small bowel bleeding in ALGIB.

    2026Scientific reports(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 432 篇论文

    合作机构(100)

    Nara Medical University合作论文 113
    京都府立医科大学合作论文 102
    大阪府済生会吹田病院合作论文 37
    近畿大学合作论文 18
    广岛大学合作论文 17
    鹿儿岛大学合作论文 17
    大阪市立大学合作论文 16
    大阪大学合作论文 15
    大分大学合作论文 15
    筑波大学合作论文 15

    机构统计